iothalamic acid has been researched along with Disease Exacerbation in 12 studies
Iothalamic Acid: A contrast medium in diagnostic radiology with properties similar to those of diatrizoic acid. It is used primarily as its sodium and meglumine (IOTHALAMATE MEGLUMINE) salts.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In studies on the progression of chronic renal failure the measurement of GFR must be very reliable." | 2.68 | Precision of glomerular filtration rate determinations for long-term slope calculations is improved by simultaneous infusion of 125I-iothalamate and 131I-hippuran. ( Apperloo, AJ; de Jong, PE; de Zeeuw, D; Donker, AJ, 1996) |
| " FGF23 exhibited a dose-response relationship with outcomes (HR=1." | 1.39 | Mineral metabolites and CKD progression in African Americans. ( Appel, LJ; Astor, BC; Isakova, T; Scialla, JJ; Wolf, M; Xie, H, 2013) |
| "We conclude that hypertension is an important marker of DN progression, and that the more HTM required for control of BP, the faster the decline of renal function." | 1.30 | Predictors of progression of diabetic nephropathy: implication for timing of kidney transplantation. ( Cheng, SS; Munn, SR; Wilson, DM, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (33.33) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sood, R | 1 |
| Surapaneni, A | 1 |
| Luo, S | 1 |
| Appel, LJ | 3 |
| Winkler, C | 1 |
| Grams, ME | 1 |
| Naik, RP | 1 |
| Xie, D | 1 |
| Joffe, MM | 1 |
| Brunelli, SM | 1 |
| Beck, G | 1 |
| Chertow, GM | 1 |
| Fink, JC | 1 |
| Greene, T | 1 |
| Hsu, CY | 1 |
| Kusek, JW | 1 |
| Landis, R | 1 |
| Lash, J | 1 |
| Levey, AS | 1 |
| O'Conner, A | 1 |
| Ojo, A | 1 |
| Rahman, M | 1 |
| Townsend, RR | 1 |
| Wang, H | 1 |
| Feldman, HI | 1 |
| Martens, DH | 1 |
| Rake, JP | 1 |
| Navis, G | 2 |
| Fidler, V | 1 |
| van Dael, CM | 1 |
| Smit, GP | 1 |
| Torres, VE | 2 |
| Grantham, JJ | 2 |
| Chapman, AB | 2 |
| Mrug, M | 1 |
| Bae, KT | 2 |
| King, BF | 2 |
| Wetzel, LH | 2 |
| Martin, D | 2 |
| Lockhart, ME | 2 |
| Bennett, WM | 2 |
| Moxey-Mims, M | 2 |
| Abebe, KZ | 1 |
| Lin, Y | 1 |
| Bost, JE | 2 |
| Tent, H | 1 |
| Waanders, F | 1 |
| Krikken, JA | 1 |
| Heerspink, HJ | 1 |
| Stevens, LA | 1 |
| Laverman, GD | 1 |
| Guay-Woodford, L | 1 |
| Landsittel, D | 1 |
| Li, J | 1 |
| Harris, PC | 1 |
| Flessner, M | 1 |
| Scialla, JJ | 2 |
| Astor, BC | 2 |
| Miller, ER | 1 |
| Beddhu, S | 1 |
| Woodward, M | 1 |
| Parekh, RS | 1 |
| Anderson, CA | 1 |
| Isakova, T | 1 |
| Xie, H | 1 |
| Wolf, M | 1 |
| Hall, PM | 1 |
| Rolin, H | 1 |
| Apperloo, AJ | 1 |
| de Zeeuw, D | 1 |
| Donker, AJ | 1 |
| de Jong, PE | 1 |
| Cheng, SS | 1 |
| Wilson, DM | 1 |
| Munn, SR | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prospective Cohort Study of Chronic Renal Insufficiency[NCT00304148] | 5,499 participants (Anticipated) | Observational | 2003-07-31 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for iothalamic acid and Disease Exacerbation
| Article | Year |
|---|---|
Iothalamate clearance and its use in large-scale clinical trials.
Topics: Clinical Trials as Topic; Disease Progression; Glomerular Filtration Rate; Humans; Iodine Radioisoto | 1995 |
3 trials available for iothalamic acid and Disease Exacerbation
| Article | Year |
|---|---|
Net endogenous acid production is associated with a faster decline in GFR in African Americans.
Topics: Acid-Base Equilibrium; Adult; Aged; Biomarkers; Black or African American; Blood Urea Nitrogen; Chi- | 2012 |
Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. The Diabetes Control and Complications (DCCT) Research Group.
Topics: Adult; Albuminuria; Blood Pressure; Cohort Studies; Diabetes Complications; Diabetes Mellitus; Diabe | 1995 |
Precision of glomerular filtration rate determinations for long-term slope calculations is improved by simultaneous infusion of 125I-iothalamate and 131I-hippuran.
Topics: Disease Progression; Follow-Up Studies; Glomerular Filtration Rate; Humans; Iodine Radioisotopes; Io | 1996 |
8 other studies available for iothalamic acid and Disease Exacerbation
| Article | Year |
|---|---|
Sickle cell trait, estimated glomerular filtration rate, and risk of adverse outcomes in chronic kidney disease.
Topics: Adult; Apolipoprotein L1; Black or African American; Cardiovascular Diseases; Creatinine; Disease Pr | 2019 |
A comparison of change in measured and estimated glomerular filtration rate in patients with nondiabetic kidney disease.
Topics: Adult; Disease Progression; Female; Glomerular Filtration Rate; Humans; Iothalamic Acid; Kidney; Kid | 2008 |
Renal function in glycogen storage disease type I, natural course, and renopreservative effects of ACE inhibition.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Child; Child, Preschool; Contrast Media; Dise | 2009 |
Potentially modifiable factors affecting the progression of autosomal dominant polycystic kidney disease.
Topics: Adult; Age Factors; Cholesterol, HDL; Disease Progression; Female; Follow-Up Studies; Glomerular Fil | 2011 |
Performance of MDRD study and CKD-EPI equations for long-term follow-up of nondiabetic patients with chronic kidney disease.
Topics: Contrast Media; Creatinine; Disease Progression; Female; Follow-Up Studies; Glomerular Filtration Ra | 2012 |
Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease.
Topics: Adolescent; Adult; Age of Onset; Disease Progression; Female; Glomerular Filtration Rate; Humans; Io | 2012 |
Mineral metabolites and CKD progression in African Americans.
Topics: Aged; Black or African American; Contrast Media; Disease Progression; Female; Fibroblast Growth Fact | 2013 |
Predictors of progression of diabetic nephropathy: implication for timing of kidney transplantation.
Topics: Adult; Age of Onset; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressu | 1997 |